Skip to the page

Data / Medical devices / United States / Spark Neuro, Inc.

Spark Neuro, Inc.: FDA-registered device maker in New York, NY, United States, 1 510(k) clearance

Spark Neuro, Inc. is registered with the FDA (registration 3029984080) in New York, NY, United States. It lists 2 device types. The FDA files 1 510(k) clearance under its listings, the newest dated August 18, 2023. Registered through 2026. FDA data exported November 2, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
3029984080
Address
224 W 35th St Ste 500 # 2031, New York, NY, United States, 10001
Owner or operator
Spark Neuro, Inc. (10089104)
Roles
Manufacturer
First device listed
November 6, 2023
Registered through
2026
Brand names listed
SPARK Neuro Cognitive Assessment Aid, SPARK Scan

Devices it lists

510(k) clearances

The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.

Decided510(k) numberDeviceProduct codeDecisionApplicantSource
August 18, 2023K231457SPARK ScanGWQSubstantially EquivalentSpark Neuro, Inc.accessdata.fda.gov

Compare with other makers

Updated August 18, 2023. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.